Anxiety Disorders and Depression Treatment Market Analysis by Drugs (Beta Blockers, TeCAs, SNRIs, TCAs, SSRI, MAOIs, Anticonvulsants, Atypical Antipsychotics and Benzodiazepines) Pipeline (ALKS 5461, Brintellix and Brexpiprazole) Analysis, Regional Outlook, Competitive Strategies and Forecasts, 2014 to 2022
Global anxiety disorders and depression treatment market is expected to witness remarkable growth over the coming seven years due to rising incidences of depression and anxiety disorders coupled with growing geriatric population base. In addition, factors such as introduction of efficient products with less side effects and increasing demand for antidepressants used in treatment of panic disorders, phobias and obsessive compulsive disorder are expected to result in increased growth of this market over the forecast period.